Survival analyses of patients with AML by mutant IDH MRD status. (A-B) CIR (A) and OS (B) of patients with IDH-mutated AML with detectable (red) and undetectable mutant IDH in CR (blue). (C-D) CIR (C) and OS (D) of patients with IDH1-mutated AML with detectable (red) and undetectable mutant IDH1 in CR (blue). (E-F) CIR (E) and OS (F) of IDH2-mutated patients with IDH2-mutated AML with detectable (red) and undetectable mutant IDH2 in CR (blue).